Navigation Links
Start of in-Patient Clinical Trials With NT-KO-003, the First Neuroprotective Drug for Multiple Sclerosis Without Immunosuppressive Effects
Date:7/19/2011

BARCELONA, July 19, 2011 /PRNewswire/ --



• NT-KO-003, developed by Advancell and Neurotec Pharma, is the first MS drug with neuroprotective effects that does not cause immunosuppression.

• This treatment is one of the first to be administered orally, whereas the few treatments available in Spain require parenteral administration (intravenous or subcutaneous) and have significant side effects.

• NeuroAdvan, the Phase IIa clinical trial, will be led by Dr Pablo Villoslada, director of Neuroimmunology at IDIBAPS, Hospital Clínic de Barcelona, ??and conducted in 105 patients in 14 hospitals in Europe. It will  represent an investment of 2.2 M €, part of which will be financed by the Catalan Local Government and the Ministry of Science and Innovation.

• This project brings to clinical proof of concept the first molecule arising from Neurotec's research in the field of acute and chronic central nervous system diseases; Advancell reaffirms its business model consisting of the development of new drugs to Phase II, and to subsequently license them to a pharmaceutical company.

The biotechnological companies Advancell and Neurotec Pharma, both based in Barcelona Science Park (PCB), Spain, have announced the initiation of a clinical Phase IIa study with NT-KO-003, an innovative oral therapy for multiple sclerosis (MS). NT-KO-003 was codeveloped by both companies and its mechanism of action is completely different from the drugs currently used to treat this disease.

The clinical trial, called NeuroAdvan, will be conducted in 105 patients from 11 hospitals in Spain (4 of them in Catalonia) and 3 in Germany, and will be led by Dr Pablo Villoslada, director of Neuroimmunology at IDIBAPS, Hospital Clínic de Barcelona, Spain. The project is being conducted in collaboration with the MRI Analysis and Research Center in Neuroimaging and Multipl
'/>"/>

SOURCE Advancell
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Convergence Pharmaceuticals Announces Start of Phase II Study for its Selective Nav 1.7 blocker CNV1014802
2. BioNeutral Starts Commercial Deployment of Its Ygiene 206 Sterilant and Ogiene Products Within Port Authority Facilities Using T.U.C.S. Cleaning Services
3. AlloSource Starts Construction on New Campus
4. TriLink Awarded SBIR Phase I Grant: Thermally Activatable Probes and Cofactors for Hot Start Ligase Chain Reaction
5. Start-Up ImmusanT Seeks to Restore Tolerance to Gluten in Celiac Disease with Immunotherapy
6. Shionogi-ViiV Healthcare Starts Phase III Trial for 572-Trii Fixed-Dose Combination HIV Therapy
7. Start of the Ulm Helmholtz Institute
8. Terso Solutions RFID Jump Start Takes the Risk Out of Implementing RFID for Hospitals and Research Laboratories Looking to Streamline Operations and Improve Regulatory Compliance
9. Intel Corporation acquires Toronto start-up CognoVision
10. Midwest Health Care Startups Raise $572 Million Through Q3 2010
11. Leonhardts Launchpads at University of Northern California Incubator for Start Up Companies to Have Grand Opening Nov. 9th, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 2015 Junto Health, a company that helps ... develop new technology solutions, today announced the launch of ... leader in health care policy consulting. Working together with ... collaborative innovation process while, at the same time, they ... policy, health care finance and the delivery of health ...
(Date:7/25/2015)... (PRWEB) , ... July 25, 2015 , ... ... for its refractometer series. It precisely checks and adjusts the surface temperature of ... measurements. , In the pharmaceutical industry, data traceability and documentation are key requirements. ...
(Date:7/24/2015)... 2015  Champions Oncology (OTC-BB: CSBR), a company engaged ... to personalize the development and use of oncology drugs, ... results for the fourth quarter and fiscal year quarter ... before market open. The company will host ... at 9:00 a.m. EDT (6:00 a.m. PDT). To participate ...
(Date:7/24/2015)... China , July 24, 2015 ... manufacturing platform , Expands product offering for chronic ... unmet medical needs in diabetes-related complications and dermatology ... 3SBio Inc., (HKEX:1530) ("3SBio" or ,the Company"), a leading ... researching, developing, manufacturing and marketing biopharmaceutical products, today announced ...
Breaking Biology Technology:Junto Health Announces a Unique Partnership with Sachs Policy Group 2Junto Health Announces a Unique Partnership with Sachs Policy Group 3Junto Health Announces a Unique Partnership with Sachs Policy Group 4It’s T-Time for Refractometers: On-site Temperature Check Now Available 2Champions Oncology to Announce Fourth Quarter Financial Results on Tuesday, July 28 23SBio Acquires Zhejiang Wansheng Pharmaceutical 23SBio Acquires Zhejiang Wansheng Pharmaceutical 33SBio Acquires Zhejiang Wansheng Pharmaceutical 4
... cells grown from human embryonic stem cells in a ... Wis.A proposition on California's ballot this November may affect ... research, experts say. If passed, the Stem Cell ... provide $3 billion in tax-free state bonds over 10 ...
... Wis. Five Wisconsin chief information officers have ... because of their ability to react quickly to rapidly ... own organizations' development of new growth opportunities. , ,The ... National and Lands' End were all among the magazine's ...
... improvement. Motherhood, apple pie, the Packers, Badgers and continuous improvement ... cause a fight after a few beers. Everyone seeks to ... the next time. Einstein's theory of human nature (my term) ... as doing the same things over and over again but ...
Cached Biology Technology:Referendum may pull California to the forefront of stem cell research 2Referendum may pull California to the forefront of stem cell research 3Referendum may pull California to the forefront of stem cell research 4Referendum may pull California to the forefront of stem cell research 5Five Wisconsin CIOs named top in nation 2The Real World 2The Real World 3
(Date:7/27/2015)... , July 27, 2015  Synaptics Inc. ... human interface solutions, today announced that Huawei has ... touchscreen solution for its stylish smartwatch. Huawei chose ... proven reliability, low power and highly responsive human ... finger. Huawei designers also required a classic round ...
(Date:7/27/2015)... LOS ANGELES , July 27, 2015 /PRNewswire/ ... providing evidence- and experience-based clinical improvement solutions, today ... coordination solution is now available on Android smartphones ... at inpatient and post-care organizations can use ZynxCarebook ... the same patient,s condition, streamline care transitions to ...
(Date:7/23/2015)... (NASDAQ: AWRE ), a leading supplier of biometrics software ... ended June 30, 2015.  Revenue for the ... 33% compared to $6.8 million in the same quarter last ... $0.3 million, or $0.01 per diluted share, which compared to ... period a year ago.  Lower revenue and ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... scientists survey five New York flu seasons , On the ... for Genomic Research (TIGR) have captured influenza evolution in action. ... , the researchers report the first large-scale project to sequence ... the rapidly evolving flu virus in a human population--and a ...
... Using functional magnetic resonance imaging, or fMRI, researchers at the ... the act of recalling a memory is a bit like ... 23 edition of the journal Science, demonstrates that the same ... are activated when a person attempts to recall that event ...
... medical research team has identified a new gene linked ... a previously discovered gene known to increase the risk ... Edinburgh and Glasgow, together with scientists from the pharmaceutical ... of the second gene, phosphodiesterase 4B (PDE4B) in the ...
Cached Biology News:First big influenza genome study reveals flu evolution 2First big influenza genome study reveals flu evolution 3First big influenza genome study reveals flu evolution 4Researchers know what you were about to say; fMRI used to detect memory storage and retrieval 2Scientists move forward understanding of schizophrenia 2
... first siRNA sequence design software in 2001, ... tools consistent with new experimental strategies and ... RNAi. With the introduction of our ... OligoEngine is pleased to offer the most ...
... GeneMarker software has been designed and created ... a biologist friendly genotyping analysis tool. We ... research groups into the software. Their main ... flexibility and low acquisition cost. GeneMarker ...
These stopping screens are for the biolistic PDS-1000 He and Hepta systems. Supplied as 500 screens....
... OLIGO is a multi-functional ... selects oligonucleotides from a sequence ... (PCR), DNA sequencing, site-directed mutagenesis, ... calculates hybridization temperature and secondary ...
Biology Products: